MHRA launches Vioxx investigation

被引:0
|
作者
不详
机构
来源
TCE | 2005年 / 768期
关键词
D O I
暂无
中图分类号
TQ [化学工业];
学科分类号
0817 ;
摘要
引用
收藏
页码:10 / 10
页数:1
相关论文
共 50 条
  • [31] Signal Detection at the MHRA
    Tregunno, P.
    Suri, S.
    Seabroke, S.
    Foy, M.
    Gandhi, S.
    [J]. DRUG SAFETY, 2009, 32 (10) : 968 - 968
  • [33] Vioxx en reclame
    不详
    [J]. Huisarts en Wetenschap, 2005, 48 (2) : 949 - 949
  • [34] Avoiding another Vioxx
    Beardsley, S
    [J]. SCIENTIFIC AMERICAN, 2005, 292 (02) : 16 - +
  • [35] Quality considerations of paediatric investigation plans for monoclonal antibodies: A regulatory perspective from the MHRA
    Hussain, Nasir
    Siapkara, Angeliki
    Branch, Sarah
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 492 (1-2) : 338 - 340
  • [36] US Senate committee launches investigation into drug pricing
    McCarthy, Michael
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [37] Reply to the Vioxx debacle
    Knudsen, JF
    Sokol, GH
    [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 (01): : 93 - 94
  • [38] The lessons of Vioxx - Reply
    Waxman, HA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13): : 1420 - 1421
  • [39] Not beyond Vioxx Yet
    不详
    [J]. SCIENTIFIC AMERICAN, 2007, 297 (01) : 16 - 16
  • [40] Will Merck survive Vioxx?
    Simons, J
    Stipp, D
    [J]. FORTUNE, 2004, 150 (09) : 90 - +